James Cloutier, D.P.M.
Podiatrist in Woonsocket, Rhode Island.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,498 in Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
James Cloutier, D.P.M. reported a CMS MIPS final score of 0/100 - below the 83.1 national average - and filed 389 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 389
- Part D claims, 2023
- 96%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
James Cloutier, D.P.M.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where James Cloutier, D.P.M. sits
This provider among podiatrist peers
Across the 2,987 podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, James Cloutier, D.P.M. writes more Part D claims than 75% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one podiatrist peer from a representative sample of 60; the gold marker is James Cloutier, D.P.M.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about James Cloutier, D.P.M.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Rhode Island
How Podiatrist compares to other specialties among Rhode Island providers
Podiatrist ranks #70 among Rhode Island's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Rhode Island provider total, by primary NUCC taxonomy. The highlighted bar is Podiatrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
James Cloutier, D.P.M.'s 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Podiatrist) - 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Podiatrist US NPIs
0/100 MIPS final score - 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Podiatrist. Quality dim: 0.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
James Cloutier, D.P.M. appears in the CMS NPPES registry as a Podiatrist provider holding D.P.M. credentials at 919 DIAMOND HILL RD, Woonsocket, RI, 02895, with a listed phone of (401) 766-4444. NPI 1487601977 was issued on 05/28/2006.
Medicare Part D records for calendar year 2023 show 389 prescription claims written by this provider, covering 236 Medicare beneficiaries and totaling roughly $4K in drug spend, split 4% brand-name and 96% generic by claim count, with an opioid prescribing rate of 4.9%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487601977 |
|---|---|
| Specialty | Podiatrist |
| Credentials | D.P.M. |
| Gender | Male |
| NPI Issued | 05/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm James Cloutier, D.P.M.'s current license status, disciplinary history, and board certifications with the Rhode Island Board of Medical Licensure and Discipline in Rhode Island before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1487601977 is the unique 10-digit identifier CMS uses to link Cloutier across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Brand vs generic prescribing mix · Generic-heavy
4% brand-name claims vs 96% generic, on 389 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 434
- Total Day Supply
- 6,189
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $313
- Generic Drug Cost
- $4K
- Opioid Claims
- 19 (4.9% rate)
- Antibiotic Claims
- 203
Patient Demographics
- Average Patient Age
- 71.9 years
- Avg HCC Risk Score
- 1.52
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 34, 65-74: 117, 75-84: 60, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What James Cloutier, D.P.M. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Azithromycin
Azithromycin
75 claims
- Cephalexin
Cephalexin
74 claims
- Methylprednisolone
Methylprednisolone
57 claims
- Ciprofloxacin Hcl
Ciprofloxacin Hcl
50 claims
- Hydrocodone-Acetam… 19
Hydrocodone-Acetaminophen
19 claims
- Terbinafine Hcl 18
Terbinafine Hcl
18 claims
- Meloxicam 17
Meloxicam
17 claims
- Clobetasol Propion… 15
Clobetasol Propionate
15 claims
| Drug | Claims |
|---|---|
| Azithromycin | 75 |
| Cephalexin | 74 |
| Methylprednisolone | 57 |
| Ciprofloxacin Hcl | 50 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 19 |
| Terbinafine Hcl | 18 |
| Meloxicam | 17 |
| Clobetasol Propionate | 15 |
| Ammonium Lactate | 14 |
| Silver Sulfadiazine | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How James Cloutier, D.P.M. fits within the Podiatrist landscape nationally.
James Cloutier, D.P.M.'s 389 claims are above the specialty average of 304.
Nearby Podiatrist Providers in Rhode Island
Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Cloutier.
Compare Podiatrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Rhode Island medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Podiatrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Rhode Island
Frequently Asked Questions
What is James Cloutier, D.P.M.'s specialty? ▼
How much does James Cloutier, D.P.M. prescribe under Medicare Part D? ▼
What is James Cloutier, D.P.M.'s Medicare quality score? ▼
Where is James Cloutier, D.P.M. located? ▼
What is James Cloutier, D.P.M.'s NPI number? ▼
Does James Cloutier, D.P.M. prescribe more brand-name or generic drugs? ▼
Does James Cloutier, D.P.M. prescribe opioids? ▼
How many Podiatrist providers are there in the US? ▼
What drugs does James Cloutier, D.P.M. prescribe most often? ▼
Does James Cloutier, D.P.M. accept Medicare? ▼
How can I verify James Cloutier, D.P.M.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology